Mutual Fund Details

ICICI Prudential Nifty Pharma Index Fund Direct - Growth

Name: ICICI Prudential Nifty Pharma Index Fund Direct - Growth
Brand: ICICI Prudential Mutual Fund

Equity Pharma

NAV

₹17.3548

as on 19 Feb 2026, 10:17 PM

₹-0.0874(0.50%)

Last Change

Scheme Ratings

rated by Value Research

Pharma

Rankings based on | as on Invalid date

Schemes Managed By

Kayzad Eghlim

Fund Manager

Nishit Patel

Ashwini Jemin Bharucha

Download the Paytm Money app now!

Invest in Stocks, F&O, Mutual Funds, IPOs, NFOS and Bonds.

Zero brokerage for 30 days
Zero account opening fees
Zero AMC for life

Scan QR code to download the app

Investment Performance

would have given a return of

₹1,10,871

₹1,21,647

₹1,80,106

₹1,83,536

Bank Account

Fixed Deposit

Regular Mutual Fund

This Fund on Paytm Money

This Mutual Fund

₹83,536

Profit (absolute return)

83.54%

in the last

max

+1% Higher Returns

With Direct Plans on Paytm Money

Investment Returns

In the last 1 month

1.47%

In the last 3 months

1.24%

In the last 6 months

1.58%

In the last 1 year

8.00%

In the last 3 years

83.54%

In the last 5 years

In the last 10 years

Absolute Returns

CAGR

Scheme Riskometer

low

low to moderate

moderate

moderately high

high

very high

Investors understand that their principal will be at very high risk

Scheme Information

ICICI Prudential Nifty Pharma Index Fund Direct - Growth

as of 31 Jan 2026, 05:30 AM

₹91.88 Cr

Scheme Asset Size

Fund Type

Open-End

Exit Load

No charges on withdrawal

0.37%

Expense Ratio

Plan

Growth

-0.35%

Cash Holding

Benchmark

NIFTY Pharma Total Return Index

Scheme Document

View

Benchmark

NIFTY Pharma Total Return Index

Exit Load

No charges on withdrawal

Scheme Document

View

Sectors Holding in this Mutual Fund

as on 31 Jan 2026

Sort By

Value

Sector

Healthcare

100.35%

₹92.20 Cr

Sectors Holding in this Mutual Fund

as on 31 Jan 2026

Sort By

Value

Sector

Healthcare

100.35%

₹92.20 Cr

Companies Holding in this Mutual Fund

as on 31 Jan 2026

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

21.38%

₹19.64 Cr

Divi's Laboratories Ltd.

9.73%

₹8.94 Cr

Cipla Ltd.

9.43%

₹8.66 Cr

Dr. Reddy's Laboratories Ltd.

9.40%

₹8.64 Cr

Lupin Ltd.

6.61%

₹6.07 Cr

Others

43.45%

₹39.92 Cr

View All

Companies Holding in this Mutual Fund

as on 31 Jan 2026

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

21.38%

₹19.64 Cr

Divi's Laboratories Ltd.

9.73%

₹8.94 Cr

Cipla Ltd.

9.43%

₹8.66 Cr

Dr. Reddy's Laboratories Ltd.

9.40%

₹8.64 Cr

Lupin Ltd.

6.61%

₹6.07 Cr

Others

43.45%

₹39.92 Cr

View All

Funds in this Category

This fund's returns:

22.37%

Return Duration

3 Years

ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth

SBI Healthcare Opportunities Fund Direct Plan-Growth

UTI Healthcare Fund Direct-Growth

About ICICI Prudential Nifty Pharma Index Fund Direct - Growth

ICICI Prudential Nifty Pharma Index Fund Direct - Growth is a Equity mutual fund scheme from ICICI Prudential Mutual Fund. This scheme was launched on Invalid date and is currently managed by its fund managers Kayzad Eghlim, Nishit Patel and Ashwini Jemin Bharucha. It has an AUM of ₹91.88 Crores and the latest NAV decalared is ₹17.355 as on 20 Feb 2026 at 3:24 pm.

ICICI Prudential Nifty Pharma Index Fund Direct - Growth scheme return performance in last 1 year is 8.00%, in last 3 years is 83.54% and 74.56% since scheme launch. The min. SIP amount to invest in this scheme is ₹1000.